Zalicus (ZLCS)
Zalicus Market Cap: 99.52M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ZLCS Market Cap Rankings
| Overall | 23rd percentile | 3579 of 4665 |
| Sector | 30th percentile | 364 of 527 in Healthcare |
| Industry | 32nd percentile | 111 of 164 in Biotechnology |
ZLCS Market Cap Range, Past 5 Years
| Minimum | 97.31M | Sep 2011 |
| Maximum | 235.36M | Jun 2011 |
| Average | 146.08M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these ZLCS related companies
ZLCS News
$ZLCS Mentioned more than normal on StockTwits - Currently at 2 x average daily social activity
about 18 hours ago by TradeIdeasQuant
about 18 hours ago by TradeIdeasQuant
finally added $ZLCS...been window shopping for a while w/ this one.
about 18 hours ago by casualtrader
about 18 hours ago by casualtrader
$ZLCS Vanguard holdings of over 1 miliion shares is a strong indicator of good things to come....
about 20 hours ago by jeremykillmer
about 20 hours ago by jeremykillmer
RT @ACInvestorBlog $ZLCS looks like it wants to clear the $1 price level very soon
about 2 days ago by gabbs
about 2 days ago by gabbs
$ZLCS http://stks.co/400Q Looks good here with plenty of room to run to the next resistance at $1.01
about 5 days ago by ACInvestorBlog
about 5 days ago by ACInvestorBlog
@irishdroog Dang it...I wish someone had paid a little attention to my question 2 days ago!!! $ZLCS is going how high?
about 7 days ago by irishdroog
about 7 days ago by irishdroog
$ZLCS Mentioned more than normal on StockTwits - Currently at 5 x average daily social activity
about 7 days ago by TradeIdeasQuant
about 7 days ago by TradeIdeasQuant
$ZLCS http://stks.co/3zca looks very interesting here... Bullish MACD cross
about 7 days ago by ACInvestorBlog
about 7 days ago by ACInvestorBlog
$ZLCS and KV/A are having a respectable day. I still believe that in the near future, $ZLCS is going to skyrocket.
about 7 days ago by Flynt2012
about 7 days ago by Flynt2012
Ugh...meant $SVU...Can't decide which to buy on weakness $ZLCS or $SUV. Which is most likely to rally the strongest?
about 9 days ago by irishdroog
about 9 days ago by irishdroog
Can't decide which to buy on weakness $ZLCS or $SUV. Which is most likely to rally the strongest?
about 9 days ago by irishdroog
about 9 days ago by irishdroog
@markf @ANDISIK any other biotech ideas? Long $AIS, looking to initiate long position $ZLCS. Thoughts?
about 9 days ago by casualtrader
about 9 days ago by casualtrader
Canaccord Genuity Reiterates a 'Buy' on Zalicus (ZLCS); Q1 Update: Synavive Phase 2b Enrollment Complete
May 15, 8:46AM Street Insider
May 15, 8:46AM Street Insider
Zalicus Completes Patient Enrollment in Phase 2b Clinical Trial of Synavive in Rheumatoid Arthritis
Apr 30, 7:30AM Business Wire
Apr 30, 7:30AM Business Wire
Zalicus Discovers Novel Multi-Target Mechanism for the Treatment of Multiple Myeloma
Apr 05, 8:00AM Business Wire
Apr 05, 8:00AM Business Wire
Zalicus Reports Financial Results for the Fourth Quarter and Year End 2011
Mar 07, 7:30AM Business Wire
Mar 07, 7:30AM Business Wire
Zalicus Successfully Completes Phase 1 Clinical Study with Reformulated Z160
Mar 05, 8:03AM Benzinga
Mar 05, 8:03AM Benzinga
Zalicus to Present at Cowen and Company 32nd Annual Health Care Conference
Feb 29, 4:30PM Business Wire
Feb 29, 4:30PM Business Wire
Zalicus and Hydra Collaborate to Advance Novel Ion Channel Product Candidates for the Treatment of Pain
Feb 09, 4:30PM Business Wire
Feb 09, 4:30PM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ZLCS | 0.95 | -0.01 | -1.04% | 99.52M |
| ZLC | 2.34 | -0.12 | -4.88% | 75.37M |
| ZIXI | 2.46 | -0.09 | -3.53% | 154.68M |
| ZIPR | 1.49 | +0.07 | +4.93% | 30.63M |
| ZIP | 10.75 | +0.40 | +3.86% | 426.45M |
| ZIOP | 5.14 | +0.12 | +2.39% | 408.48M |
| ZION | 18.51 | -0.52 | -2.73% | 3.504B |
| ZINC | 8.86 | -0.17 | -1.88% | 387.36M |
| ZIGO | 16.58 | -0.33 | -1.95% | 301.26M |
| ZHNE | 0.84 | -0.06 | -6.67% | 25.91M |